INTRODUCTION
Recombinant adenovirus serotype 5 (Ad5) vector-based vaccines are being developed for multiple pathogens, including Ebola (1), influenza (2) , hepatitis C (3), and Trypanosoma cruzi (4); however, an Ad5 vector-based vaccine for HIV-1 showed no efficacy in humans (5, 6) . Ad5 vectors, particularly at high doses, have been reported to induce partially exhausted CD8 + T cell responses with decreased functionality (7, 8) . Ad5-elicited CD8 + T cells exhibit a markedly elevated expression of programmed cell death 1 (PD-1) with reduced production of interleukin-2 (IL-2) and tumor necrosis factor-a (TNF-a) and also show impaired anamnestic expansion upon second antigen exposure (7) (8) (9) . Understanding the mechanisms that negatively regulate the functionality of vaccine-elicited T cell responses is critical to the rational design of improved vaccines. CD4 + T cells play a major role in orchestrating the generation of antigen-specific CD8 + T cell responses after adenovirus vector immunization (10) (11) (12) (13) and dictate viral clearance after lymphocytic choriomeningitis virus (LCMV) or simian immunodeficiency virus (SIV) infection (14, 15) . Moreover, Ad5 vectors have been shown to elicit CD4 + T cells that coexpress interferon-g (IFN-g) and IL-10 (16). However, the functional significance of these IL-10-producing CD4 + T cells remains unclear. In particular, the extent to which these IL-10 + CD4 + T cells may modulate Ad5 vaccine-elicited CD8 + T cell magnitude or function has not been explored previously. Furthermore, the pathways that regulate these IL-10-producing cells remain unknown.
To define the mechanism responsible for the distinct immune phenotype elicited by Ad5 vectors, we evaluated CD4 + and CD8 + T cell responses after Ad5 immunization of mice and rhesus monkeys. We found that Ad5 vectors induced antigen-specific inhibitory IL-10 + CD4 + T cells that markedly suppressed the frequency, functionality, and protective efficacy of antigen-specific CD8 + T cell responses in mice. Moreover, induction of these inhibitory IL-10 + CD4 + T cells was dependent on IL-27. Together, these data demonstrate that understanding the negative immunologic regulatory pathways of vaccine vectors may pave the way for designing improved vaccines.
RESULTS

Ad5 immunization induces CD8
+ T cells with a dysfunctional phenotype in a dose-dependent manner We initiated studies to evaluate the phenotype of antigen-specific CD8 + T cells elicited by Ad5 vectors. We compared the phenotypes of CD8 + T cells on day 10, which is the peak of CD4 + T cell responses ( fig. S1A ), after immunization with escalating doses [10 8 , 10 9 , or 10 10 viral particles (vp)] of Ad5-expressing SIV mac239 Gag (Ad5-Gag) (Fig. 1 , A to D). We did not observe any notable difference in the frequency of Gag-specific IFN-g + CD8 + T cells at these doses (Fig. 1A) . However, the frequency of Gag-specific IFN-g + CD8 + T cells expressing the inhibitory markers PD-1 and TIM (T cell immunoglobulin mucin)-3 was increased in Ad5-Gag-immunized mice in a dosedependent manner (Fig. 1 , B and C). We next evaluated the cytokine polyfunctionality (measured by the coexpression of IFN-g, TNF-a, and IL-2) of these Gag-specific CD8 + T cells. The frequency of polyfunctional CD8 + T cells was reduced in mice vaccinated with the highest dose of Ad5-Gag (10 10 vp) (Fig. 1D) , consistent with previous reports from our laboratory and those of others (7, 9, 17) .
We next evaluated whether the phenotype observed in antigenspecific CD8 + T cells persisted over time. We observed different kinetics of CD8 + T cell responses (fig. S1B), as previously described (7, 8 S2 and tables S1 to S6).
Ad5 immunization induced OVAspecific CD8 + T cells that expressed higher levels of inhibitory molecules, including Pdcd1 (encodes PD-1) and Ctla4 [encodes cytotoxic T lymphocyte antigen 4 (CTLA-4)], as compared with Ad26 ( Fig. 2A) . In addition, after Ad5-OVA immunization, the expression was increased for early growth response protein (EGR) family genes (Egr1, Egr2, and Egr3) ( Fig. 2A) , which regulate the immune system (18) . Egr2 is a downstream gene of Foxo3A and transforming growth factor-b, two key regulators of immune response (19) . In contrast, genes that decreased upon Ad5 immunization included Il2 and Il2ra ( Fig. 2A) , which are important in the development of CD8 T cell responses (20) .
We next performed gene set enrichment analysis (GSEA) (21) to identify (Fig. 2 , B to E). We found that after Ad5 immunization, CD8 + T cells exhibited a decreased effector signature (Fig. 2B) , with a phenotype highlighted by increased exhaustion [false discovery rate (FDR) = 0.001; P < 0.001] (Fig. 2C ) and anergy (FDR = 0.13; P < 0.001) (Fig. 2D) signatures. Next, we tested for the enrichment of canonical gene sets from the MSigDB and Ingenuity (IPA) databases. GSEA revealed that Ad5-elicited CD8 + T cells induced pathways such as IL-10, nuclear factor of activated T cells (NFAT), and Foxo3A signaling, suggesting the induction of regulatory and exhaustion pathways upon Ad5 immunization (Fig. 2, E and F) .
In particular, we observed enrichment of IL-10 target genes in Ad5-induced CD8 + T cells as compared with control Ad26-induced CD8 + T cells (Fig. 2F ). IL-10 is an inhibitory cytokine that regulates several transcriptional and chromatin repressors, plays an important role in impairing antiviral immunity during chronic viral infections such as HIV-1 (22) , and suppresses viral clearance in animal models (23, 24) . IL-10 acts directly through inhibition of proliferation, differentiation, cytokine production (IL-2/IFN-g), and tyrosine phosphorylation downstream of CD28 signaling in T cells (25) , and indirectly through suppression of critical antigen-presenting cell (APC) functions by inhibiting cytokine production and preventing up-regulation of major histocompatibility complex (MHC)/costimulatory molecules upon maturation (25) . We observed decreased IL-2 signaling and Tob1 signaling-mediated T cell activation (Fig. 2, E and F) . These data suggest 
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IL-10 blockade enhances antigen-specific CD8 + T cell functionality and protective efficacy We next evaluated whether IL-10 blockade would improve antigenspecific CD8 + T cell responses elicited by Ad5 vectors. We immunized transgenic IL-10 knockout (IL-10KO) mice with Ad5-Gag and measured Gag-specific CD8 + T cell responses. We observed a 1.7-fold increase in the frequency of IFN-g expression by Gag-specific CD8 + T cells in IL-10KO mice as compared with wild-type mice (P = 0.01) (Fig. 3A) . We also observed a 2.6-fold increase in the frequency of TNFa (P = 0.0007) (Fig. 3C ) in Ad5-Gag-immunized IL-10KO mice as compared with wild-type control mice. Gag-specific CD8 + T cell cytokine polyfunctionality (P = 0.001) (Fig. 3D ) was also enhanced in IL-10KO mice. Consistent with these findings, anti-IL-10 receptor (IL-10r) blockade by monoclonal antibody (mAb) administration similarly led to an increased frequency of TNF-a + (P = 0.0005) ( Fig. 3E ) and IL-2 + (P = 0.013) (Fig. 3F ) CD8 + T cells as compared with isotype control antibody administration after Ad5-Gag immunization.
To determine the functional relevance of IL-10 blockade, we assessed the protective efficacy of antigen-specific CD8 + T cells with or without IL-10 blockade. About 5 × 10 2 naïve OT-I CD8 + T cells from CD45.1 congenic mice were adoptively transferred into CD45.2 naïve mice and immunized with 10 10 vp of Ad5-OVA. Mice were divided into two experimental groups: (i) mice treated with 200 mg of anti-IL-10r mAb every other day from day −1 through day 7 and (ii) mice treated with isotype control mAb. Ten days after immunization, 5 × 10 4 OT-I CD8 + T cells were subjected to fluorescence-activated cell sorting (FACS) and adoptively transferred into congenic naïve mice to equalize the number of antigen-specific CD8 + T cells before challenge. One day after the transfer, mice were challenged intravenously with 1 × 10 5 colony-forming units (CFU) of recombinant Listeria monocytogenes expressing OVA (Fig. 3G ). OT-I CD8 + T cells from mice treated with anti-IL-10r mAb afforded a significant reduction of L. monocytogenes bacterial loads (P = 0.01) (Fig. 3H ), whereas the same number of OT-I CD8 + T cells from animals treated with isotype control mAb was unable to reduce bacterial loads as compared with control mice. These data demonstrate that IL-10 blockade augments vaccineelicited functional CD8 + T cells and improves protective efficacy in this model. S3 ). Gag-specific IFN-g + IL-10 + CD4 + T cells expressed more T-bet (P = 0.007), interferon regulatory factor 4 (IRF-4) (P = 0.007), and CTLA-4 (P = 0.0002) than Gag-specific IFN-g + IL-10 − CD4 + T cells did. Expression of B cell lymphoma 6 (BCL-6) and CD226 was significantly down-regulated in these cells (P = 0.007 and P = 0.001, respectively).
We next evaluated whether Gag-specific (Fig. 4E ). These data demonstrate that IL-10-producing CD4 + T cells suppress CD8 + T cell responses after Ad5 immunization.
CD4
+ T cell phenotype observed after Ad5 immunization is not correlated with antigen load or persistence To confirm that the differences observed between Ad5 and Ad26 immunization were not an artifact arising from the fact that mice do not express the human receptor CD46, which is the primary attachment receptor of Ad26 (27) , we repeated these experiments in human CD46 transgenic (hCD46tg) mice. A phenotype of Gagspecific CD4 + T cells that is comparable in terms of IFN-g, IL-10, PD-1, and TIM-3 expression was observed in hCD46tg and wildtype mice after Ad26-Gag immunization ( fig. S4 , A to D). To address whether differences in antigen expression led to the observed phenotypic differences, we used an in vivo imaging system (IVIS) to detect luciferase (Luc) transgene expression in mice immunized with Ad5 or Ad26 expressing Luc ( fig. S5A ). We observed comparable Luc expression at the injection site 3 hours after immunization. Twenty-four hours after immunization, Luc expression was 7.5-fold lower in Ad5-Luc-immunized mice compared with Ad26-Lucimmunized mice (P = 0.02). In addition, a 5.1-fold-higher Luc expression in Ad26-immunized mice as compared with Ad5-immunized mice persisted until 21 days (P = 0.02) ( fig. S5A) . Thus, the dysfunctional phenotype observed after Ad5 immunization was not due to elevated or prolonged transgene expression in Ad5-immunized mice.
We also determined whether Ad5 and Ad26 differ with respect to the phenotype of Gag-specific CD4 + T cells as a result of liver tropism of Ad5 (28) . To address this, we used a chimeric Ad5 vector that has hypervariable regions (HVRs) replaced with those from the nonhepatotropic Ad48 vector, referred to as Ad5HVR48 (29) . No differences in IL-10, PD-1, or TIM-3 expression by Gagspecific IFN-g + CD4 + T cells were observed between Ad5HVR48-Gag-and Ad5-Gag-immunized mice ( fig. S5, B to D) . Together, these data suggest that the distinct CD4 + T cell phenotype observed after Ad5 immunization is not associated with differences in receptor usage, liver tropism, or transgene persistence.
Altered CD4
+ T cell phenotype in rhesus monkeys after Ad5 immunization Last, we investigated whether these findings in mice were translatable to nonhuman primates. Peripheral blood mononuclear cells (PBMCs) were collected from 10 rhesus macaques 2 weeks after their immunization with 10 10 vp of Ad5-Gag or Ad26-Gag (n = 5 per group). We observed an eightfold increase in the frequency of Gag-specific IL-10 + IFN-g + CD4 + T cells (P = 0.015) (Fig. 5A ) in Ad5-Gag-immunized macaques as compared with control Ad26-Gag-immunized macaques. We also observed a lower frequency of Gag-specific CD4 + T cells coproducing IL-2 and IFN-g (P = 0.031) (Fig. 5B) and reduced Gag-specific CD4 + T cell cytokine polyfunctionality (Fig. 5C ) in Ad5-Gag-immunized animals as compared with Ad26-Gag-immunized animals. In addition, Gag-specific IFN-g
T cells from Ad5-Gag-immunized monkeys had elevated PD-1 expression (P = 0.007) as compared with those from Ad26-Gag-immunized animals (Fig. 5D) . Together, these data demonstrate that the frequency of dysfunctional CD4 + T cells is increased after Ad5 immunization in both mice and rhesus monkeys. (Fig. 6A) .
GSEA pathway revealed that after Ad5-OVA immunization, OVA-specific CD4 + T cells exhibit significant enrichment in gene signatures for T H 1 differentiation (FDR < 0.001; P = 0.001) (Fig. 6B) , T FH differentiation (FDR < 0.001; P < 0.001) (Fig. 6C) , exhaustion (FDR < 0.001; P < 0.001) (Fig. 6D) , and anergy (FDR < 0.001; P < 0.001) (Fig. 6E) (18, 30-32) . Moreover, Ad5-elicited CD4 + T cells had increased expression of NFAT target genes, analogous to that observed in Ad5-elicited CD8 + T cells (Fig. 6 , F and G). Apoptosis signaling was also increased, highlighting potential survival defects of these cells upon Ad5 immunization. We observed enrichment of IL-10 signaling upon Ad5 immunization (Fig. 6F) , analogous to that seen with CD8 + T cells. These data suggest that Ad5 vectors induce highly dysregulated CD4 + T cell responses that do not fully match classical definitions.
We next investigated which pathways regulated the production of IL-10 by Ad5-induced CD4 + T cells. Both IL-12 and IL-27 pathways have been reported to be involved in IL-10 production (33, 34). We observed that both IL-12 and IL-27 signaling (FDR < 0.0001) (Fig. 6 , F to I) were induced after Ad5 immunization as compared with Ad26 immunization. Together, these data demonstrate that Ad5 vaccination elicited CD4 + T cells Data are representative of three independent experiments, with five to eight animals per group. Each dot represents an individual mouse (n = 5 to 8). P values were calculated using Mann-Whitney U test. Data are presented as means ± SEM.
with a dysregulated phenotype, including expression of several inhibitory molecules as well as IL-12 and IL-27 pathways. 
IL-10 expression by CD4 + T cells after Ad5 immunization is not IL-12-dependent
IL-10 expression by CD4
+ T cells after Ad5 immunization is IL-27-dependent IL-27 has been shown to be associated with the induction of IL-10 production by T cells in several models of autoimmune disease and infection (36) . Thus, we next examined whether elevated IL-27 expression correlated with the dysfunctional phenotype observed in CD4 + T cells after Ad5 immunization. Mice lacking the a chain of the IL-27 receptor (IL-27raKO) were immunized, and CD4 + T cells were evaluated by intracellular cytokine staining (ICS) 10 days after immunization. Production of IL-10 (P = 0.007) by Gag-specific IFNg + CD4 + T cells was markedly impaired in Ad5-Gag-immunized IL27raKO mice as compared with wild-type mice (Fig. 7A) . In contrast, expression of IL-2 and TNF-a by Gag-specific IFN-g + CD4 + T cells was elevated 2-and 1.3-fold, respectively, in Ad5-Gag-immunized IL-27raKO mice as compared with wild-type mice (P = 0.007) (Fig.  7, B and C) . Moreover, the lack of IL-27 signaling improved CD4 + T cell cytokine polyfunctionality (Fig. 7D) .
We next tested the impact of IL-27 signaling on PD-1, TIM-3, and CD226 expression by Gag-specific IFN-g + CD4 + T cells. No changes in the expression of PD-1 or TIM-3 were observed after Ad5-Gag immunization in IL-27RraKO mice as compared to wildtype mice. Gag-specific IFN-g + CD4 + T cells up-regulated the expression of CD226 in Ad5-Gag-immunized IL-27raKO mice as compared with wild-type mice (Fig. 7E) . In addition, Gag-specific IFN-g + CD4 + T cells up-regulated T-bet (P = 0.055) and BCL-6 (P = 0.007) and down-regulated IRF-4 (P = 0.007) in Ad5-Gag-immunized IL27raKO mice as compared with wild-type mice (Fig. 6F) . These data suggest that IL-27 blockade enhances CD4 + T cell effector phenotype. Consistent with these findings, the absence of IL-27 using IL-27/ IL-35 double-knockout mice (EBI3 subunit protein KO) or blockade with anti-IL-27 (p28 subunit protein) mAb (aIL-27mAb) yielded similar results, as compared to IL-27raKO mice, after Ad5-Gag immunization ( fig. S7 ). These data demonstrate that Ad5 vectors trigger IL-27 expression that is correlated with up-regulation of IL-10 by Gag-specific IFN-g + CD4 + T cells.
DISCUSSION
In this study, we demonstrate that Ad5 vectors induce high frequencies of suppressive IL-10 + CD4 + T cells in both mice and rhesus monkeys. These IL-10 + CD4 + T cells are dependent on IL-27, suppress vaccine-elicited CD8 + T cell magnitude and function, and inhibit protective efficacy in vivo. These data suggest that the cytokine networks and transcriptomic profiles induced by Ad5 vectors underlie the dysfunctional phenotype of CD8 + T cells induced by Ad5. These data raise the possibility of IL-10 or IL-27 inhibition being explored as a therapeutic strategy to improve the immunogenicity and protective efficacy of viral vector-based vaccines with phenotypes similar to those seen in this study.
S C I E N C E I M M U N O L O G Y | R E S E A R C H A R T I C L E
IL-27 was initially classified as a proinflammatory cytokine because of its ability to induce the production of IFN-g by T cells (33) . Indeed, after subunit vaccination, IL-27 is required to trigger CD4 + and CD8 + T cell responses (37) . A role for IL-27 as a negative regulator of T cell responses has also been reported in studies showing the antagonistic effects of IL-27 on T H 1, T H 2, and T H 17 CD4 + T cell responses in vivo (33) . CD4 + T cells from IL-27 receptordeficient mice chronically infected with Mycobacterium tuberculosis maintain elevated PD-1 but display increased IL-2 expression compared with cells from wild-type animals, resulting in bacterial clearance (38) . In the present study, we show that IL-27 blockade improves Ad5-elicited CD4 + T cell phenotype by inhibiting IL-10 expression and increasing IL-2, TNF-a, and CD226 expression. Our data also corroborate a previous report showing that CD226 expression is regulated by IL-27 (39) . IL-27 has already been correlated with limitations in the size and duration of T cell responses in several models of pathogenic infections and autoimmunity (40) . These data reflect a role for IL-27 in triggering dysfunctional T cells after adenovirus vector vaccination. These data further suggest that IL-27 blockade could represent a strategy to prevent the generation of suppressive IL-10 + CD4 + T cells after vaccination. The potential therapeutic benefit of IL-10 blockade was described as a strategy to recover T cell function and to improve viral clearance in a model of persistent LCMV infection (23) . In our experiments, we observed a suppressive effect of antigen-specific IL-10 + CD4
+ T cells on antigen-specific CD8 + T cells after vaccination, and blockade of IL-10 also improved CD8 + T cell cytokine polyfunctionality with increased coexpression of IFN-g, IL-2, and TNF-a after Ad5 vaccination. We observed these effects despite the fact that IL-10 levels were substantially reduced in our model as compared with mice chronically infected with LCMV clone 13.
We have previously reported that antigen-specific CD8 + T cells from Ad5-immunized mice fail to up-regulate the IL-7 receptor (CD127) and CD62L and that these cells have sustained elevated PD-1 expression in comparison with other adenovirus serotypes (7, 8) . In this study, we show that Ad5-elicited CD4 + T cells also up-regulate the expression of PD-1 and TIM-3. In addition, the transcriptional profile of Ad5-elicited CD8 + T cells and CD4 + T cells reveals a dysfunctional phenotype, with up-regulation of several inhibitory markers and enrichment of transcriptional signatures for anergy and exhaustion in both cell populations. Thus, Ad5 vectors, particularly at high doses, induce both CD4 + and CD8 + T cell responses that are phenotypically, functionally, and transcriptionally similar to those of exhausted cells observed during chronic viral infection. These data also raise the possibility that the observed increase in HIV-1 acquisition during the STEP trial (HVTN502) could be associated with the Ad5 induction of CD4 + T cells with phenotypes similar to those of HIV-1 reservoirs (41). However, besides the partially exhausted phenotype induced by Ad5, CD8 + T cells can still confer protection in different viral challenge models (42, 43) .
Despite the fact that IL-27 was identified to be playing a major role by inducing the phenotype observed in CD4 + T cells, its direct effect on CD8 + T cells remains to be elucidated. Our study shows that IL-10 derived from CD4 + T cells is enough to suppress CD8 + T cells in mice, but future studies need to be performed to clarify whether the same mechanism will translate to both monkeys and humans.
Together, our data in mice suggest that Ad5 vectors elicit dysfunctional CD4 + and CD8 + T cell responses through a mechanism that involves IL-27 induction of suppressive IL-10 + CD4 + T cells. Although this model may be specific for Ad5 vectors, it is likely that other cytokine networks and transcriptomic pathways dictate the phenotype of T cell responses elicited by other adenovirus serotypes and viral vectors. Therapeutic strategies may be developed to exploit these pathways to enhance the immunogenicity and protective efficacy of viral vector-based vaccines.
MATERIALS AND METHODS
Study design
The present study aimed to investigate the role of IL-10-producing CD4 + T cells that affect the efficacy of Ad5 vector vaccine after immunization. Our approach was conducted using intracellular flow cytometry, microarray analysis, cellular adoptive transfer, and bacterial challenge experiments, as described in the figure legends. Age-and sex-matched mice and monkeys were randomly divided into experimental groups containing at least five animals per group; this step was repeated at least two times, except for the monkey study (Fig. 5) . /J (OT-II), and B6.FVB-Tg(CD46)2Gsv/J (hCD46Tg) animals were purchased from the Jackson Laboratory (Bar Harbor, ME). Mice were immunized intramuscularly in the quadriceps with 10 8 to 10 10 vp of each vector in a volume of 100 ml divided equally between the two legs, with the previously described E1/E3-deleted Ad5, Ad26, or Ad5HVR48 vectors expressing SIV mac239 Gag, OVA, or Luc. All animal experimental procedures were performed in accordance with the guidelines of the Beth Israel Deaconess Medical Center Institutional Animal Care and Use Committee. The monoclonal anti-IL-10r antibody clone 1B1.3A (BioXCell) or control immunoglobulin G (IgG) was administered intraperitoneally (200 mg per mouse) every other day from day −1 to day 7 (44) . The anti-IL-27 mAb clone MM27-7B1 (BioLegend) or control IgG was administered intraperitoneally (500 mg per mouse) on days −2, 0, and +2.
Animals
Flow cytometry, intracellular cytokine staining, and cell sorting Lymphocytes were isolated from the spleen, stained, and analyzed by flow cytometry, as previously described (10) . Antigen-specific CD4 + and CD8 + T cells were examined with MHC class I or class II tetramers. MHC class I and MHC class II tetramers were provided by the NIH Tetramer Core Facility (Emory University, Atlanta, GA). For ICS staining, cells were restimulated in vitro for 1 hour at 37°C with an overlapping SIV mac239 Gag peptide pool (1 mg/ml). After this incubation, brefeldin A and monensin (BioLegend) were added, and samples were incubated for an additional 6 hours at 37°C. Cells were subsequently washed, stained, and permeabilized with the Cytofix/ Cytoperm kit (BD Biosciences) or the Foxp3 Fixation/Permeabilization kit (eBioscience). Cells were acquired using an LSR II flow cytometer (BD Biosciences), and data were analyzed using FlowJo v.9.8.3 (Treestar). Cell sorting was performed using the FACSAria III Special Order (BD Biosciences) with >98% purity. Surface antibodies included anti-CD4 (RM4-5), anti-CD8a (53-6.7), anti-CD11b (M1/70), antiCD11c (N418), anti-CD44 (IM7), anti-CD45.1 (A20), anti-CD45.2 (104), anti-CD226 (10E5), anti-PD-1 (RMP1-30), and anti-TIM-3 (RMT3-23). Intracellular antibodies included anti-IL-2 (JES6-5H4), anti-IL-10 (JES5-16E3), anti-IL-12 (C15.6), anti-IL-27 (MM27-7B1), anti-BCL-2 (BCL/10C4), anti-BCL-6 (K112-91), anti-CTLA-4 (UC10-4F10-11), anti-Eomes (Dan11mag), anti-Foxp3 (FJK-16S), anti-IFN-g (XMG1.2), anti-IRF-4 (3E4), anti-T-bet (4B10), and anti-TNF-a (MP6-XT22). All antibodies were purchased from BD Biosciences, eBioscience, or BioLegend. Rhesus monkey staining antibodies included anti-CD3 (SP34-2), anti-CD4 (L200), anti-CD8 (RPA-T8), anti-CD69 (FN50), anti-IL-2 (MQ1-17H12), anti-IFN-g (B27) (BD Bioscience), and anti-IL-10 (JES3-9D7) (eBioscience). Vital dye-exclusion stain kit (LIVE/DEAD) was purchased from Life Technologies. 10 vp of Ad5-Gag (Fig. 4D) . For the recombinant L. monocytogenes challenge study, 5 × 10 2 OT-I cells were isolated using the T Cell Isolation Kit (STEMCELL Technologies) and transferred into naïve mice. Ten days after immunization, OT-I CD45.1 T cells were subjected to FACS, and 5 × 10 4 cells were transferred a day before the L. monocytogenes challenge.
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Microarray data acquisition and analysis Gene expression profiling was performed as previously described (45, 46) , and data were uploaded (GSE73118). Briefly, OVA-specific CD4 + T cells were sorted to ≥98% purity on a FACSAria III cytometer (BD Biosciences). Sorted cells were stored at −80°C in 1 ml of TRIzol (Life Sciences). RNA extraction was performed using the RNAdvance Tissue Isolation kit (Agencourt), as per the manufacturer's instructions. cDNA synthesis was performed using the Ovation Pico WTA V2 kit (NuGEN) following the manufacturer's instructions. Proper amplification of cDNA was confirmed using an Agilent 2100 Bioanalyzer (Agilent Technologies) and performed at the Harvard Biopolymers Facility. cDNA was subsequently fragmented and biotinylated using Encore Biotin Module 4200 (NuGEN). cDNA was hybridized to a Mouse Genome 430 V2.0 chip (Affymetrix) at the Microarray Core of Dana-Farber Cancer Institute. Analysis of gene array output data was conducted using the statistical language R (http://www.r-project.org/) and the Linear Models for Microarray Data (LIMMA) statistical package from Bioconductor (https://www. bioconductor.org/). Gene intensities were log 2-transformed before they were normalized using the quantile normalization method. Differentially expressed genes in CD8 and CD4 cells were modulated by Ad26 or Ad5. The moderated t test implemented in the R LIMMA package was used to assess the statistical significance (P < 0.05) of the differential expression of genes between Ad5 and Ad26. We used GSEA (21) to identify enriched biological pathways that were modulated between Ad5 and Ad26 in both CD4 and CD8 cells. GSEA is a statistical approach that analyzes the distribution of a defined set of genes ("gene set") against a separate rank-ordered gene list. We used the preranked list option of GSEA and tested for the enrichment of C2 and C7 MSigDB gene sets (http://software.broadinstitute.org/ gsea/msigdb). Genes were ranked by the fold change (FC) between Ad5 and Ad26 (from the highest FC to the lowest FC). The ranked list was submitted to GSEA; for each gene set, enrichment score was calculated by reflecting the degree of overrepresentation at the top (or bottom) of the ranked list. GSEA allows for the identification of a core list of genes (leading-edge genes) that contribute to the enrichment score. A gene-based permutation test (1000 permutations) was used to normalize the enrichment score to correct for the size of the gene set, to assess the statistical significance (nominal P value) of the enrichment score, and to calculate the probability of the gene set being the FDR. We discarded gene sets with FDRs >5%. Gene set-normalized enrichment scores in all figures were plotted using R (21).
In vivo bioluminescence Mice were initially shaved using Nair Hair Removal (Church & Dwight Co.). Animals were immunized intramuscularly (quadriceps) with 10 10 vp of Ad5 or Ad26 expressing Luc. At selected time points (3 hours, 6 hours, 12 hours, 24 hours, and 21 days), animals were injected intraperitoneally with 150 ml of XenoLight RediJect D-Luciferin Ultra (PerkinElmer; 150 mg/kg). After 10 min, imaging was performed for 2 min (exposure time) using the IVIS Series 100 (Xenogen). Images and luminescence measurements were performed using Living Image software (version 2.50.1; Xenogen) (47) .
Statistical analysis
Statistical analysis was performed using two-tailed nonparametric Mann-Whitney U test or ordinary one-way analysis of variance with multiple comparison test using Prism version 6.0c (GraphPad Software). Data are presented as means ± SEM. Table S1 . Genes differentially expressed in CD8 + T cells after Ad5 versus Ad26 immunization. Table S2 . Genes differentially expressed in CD4 + T cells after Ad5 versus Ad26 immunization. 
SUPPLEMENTARY MATERIALS
